Prostate cancer is a malignancy that develops in the prostate gland, a small organ located below the bladder and surrounding part of the urethra. It is one of the most commonly diagnosed cancers among men.

Researchers continue to investigate the genetic, hormonal, and immune-related factors involved in prostate cancer development and progression.

At Bay Biosciences, we provide high-quality Prostate Cancer PBMC Samples, prostate cancer patient blood samples, serum, plasma, and many other high-quality human biospecimens for prostate cancer research.

These biospecimens can support cancer research, immunological studies, biomarker discovery, diagnostics, and drug development.

Prostate Cancer PBMC & Serum Samples For Research

Understanding Prostate Cancer

Prostate cancer develops when abnormal cells in the prostate gland begin to grow uncontrollably. The prostate produces fluid that contributes to semen and is influenced by male sex hormones, including testosterone.

Most prostate cancers are adenocarcinomas, which develop from glandular cells of the prostate.

Some tumors grow slowly and may remain confined to the prostate for many years.

Other forms are more aggressive and can invade nearby tissues or spread to distant organs, including the bones.

The biological behavior of prostate cancer varies among patients.

Therefore, scientists use prostate cancer samples for research into tumor characteristics, genetic alterations, hormone signaling, and immune responses. This helps them better understand disease progression and treatment outcomes.

Signs and Symptoms of Prostate Cancer

Early prostate cancer may not cause noticeable symptoms. As the disease progresses, some patients may develop urinary or other symptoms.

Common symptoms may include:

These symptoms can also occur with noncancerous prostate conditions. Therefore, clinical evaluation and appropriate diagnostic testing are required to determine the underlying cause.

Causes of Prostate Cancer

The exact cause of prostate cancer is not fully understood. However, the disease develops when genetic changes disrupt the normal regulation of prostate cell growth and division.

Firstly, mutations may affect genes that control cell growth, DNA repair, and cell survival. These changes can allow abnormal prostate cells to multiply uncontrollably.

Secondly, inherited genetic alterations can increase susceptibility to prostate cancer in some individuals. For example, alterations involving genes associated with DNA repair may contribute to an increased risk.

Thirdly, prostate cancer development is influenced by age and hormonal factors. Androgens, including testosterone, play an important role in prostate cell growth and continue to be investigated in prostate cancer research.

Finally, researchers continue to investigate interactions between genetic, environmental, lifestyle, and biological factors that may influence prostate cancer development and progression.

Risk Factors for Prostate Cancer

Several factors can increase an individual’s likelihood of developing prostate cancer.

Firstly, age is one of the strongest risk factors. The likelihood of prostate cancer increases as men get older.

Secondly, family history can influence risk. Men with a father, brother, or son diagnosed with prostate cancer may have a higher risk of developing the disease.

Thirdly, genetic factors can contribute to susceptibility. Certain inherited genetic changes are associated with increased prostate cancer risk.

Finally, race and ethnicity can influence prostate cancer risk and disease outcomes.

Research has shown differences in incidence and mortality among racial and ethnic groups.

Diagnosis of Prostate Cancer

The diagnosis of prostate cancer begins with a review of the patient’s medical history, symptoms, and risk factors.

Healthcare providers may then use several diagnostic approaches.

Firstly, a PSA blood test measures the concentration of prostate-specific antigen in the blood. Physicians may evaluate PSA levels alongside other clinical findings.

Secondly, a digital rectal examination (DRE) may be performed to assess the prostate for abnormalities.

Thirdly, imaging techniques such as magnetic resonance imaging (MRI) can help identify suspicious areas within the prostate and guide biopsy procedures.

Finally, a prostate biopsy provides tissue for microscopic examination. Pathologists evaluate the tissue to determine whether cancer cells are present and may assign a Gleason grade or Grade Group to characterize tumor aggressiveness.

Additional imaging and laboratory tests may be performed when physicians need to determine whether prostate cancer has spread beyond the prostate.

Treatment of Prostate Cancer

Treatment depends on several factors, including the stage and grade of cancer, whether the disease has spread, the patient’s overall health, and individual treatment preferences.

Firstly, active surveillance may be appropriate for some patients with localized, low-risk prostate cancer. Physicians monitor the disease through PSA testing, imaging, biopsies, and other assessments.

Secondly, surgery may be used to remove the prostate and surrounding tissues in selected patients. Radical prostatectomy is one surgical treatment for localized prostate cancer.

Thirdly, radiation therapy uses high-energy radiation to destroy cancer cells. External-beam radiation and brachytherapy are two commonly used approaches.

Fourthly, hormone therapy, also called androgen deprivation therapy, reduces or blocks the effects of male hormones that can stimulate prostate cancer growth.

Finally, physicians may use chemotherapy, targeted therapy, immunotherapy, or other systemic treatments for advanced or metastatic prostate cancer depending on the characteristics of the disease.

Applications of Prostate Cancer PBMC Samples

Prostate Cancer PBMC Samples are valuable research resources because they provide access to immune cells obtained from the peripheral blood of patients diagnosed with prostate cancer.

Immunological Research

Peripheral blood mononuclear cells contain immune cell populations such as lymphocytes and monocytes. Researchers can study these cells to investigate immune responses associated with prostate cancer. 

Biomarker Discovery

Researchers may use Prostate Cancer PBMC Samples alongside matching serum and plasma to investigate potential biomarkers associated with disease characteristics.

Drug Discovery and Development

PBMCs can support studies investigating how immune cells respond to potential therapeutic compounds or immunomodulatory approaches.

Precision Medicine Research

Researchers can combine PBMC-derived cellular information with serum, plasma, genetic, and clinical data to investigate biological differences between patients.

Prostate Cancer Blood Samples for Research

Prostate cancer blood samples for research may include peripheral whole blood, serum, plasma, and PBMCs. Each sample type provides different information.

Whole blood can support cellular and hematological investigations.

Similarly, serum and plasma can be used to study circulating proteins, hormones, nucleic acids, and other potential biomarkers.

Frequently Asked Questions

What types of human biospecimens for prostate cancer research are available?

Prostate Cancer Samples for research include PBMCs, serum, plasma, tumor tissue, FFPE tissue, etc.

What are prostate cancer biomarker research samples used to study?

Prostate cancer biomarker research samples may be used to investigate proteins, nucleic acids, immune markers, and other biological indicators associated with prostate cancer.

Are Prostate Cancer Samples for research ethically sourced?

Yes. All biospecimens available on our website are sourced with ethical guidelines in mind.

Supporting Your Research with Bay Biosciences

At Bay Biosciences, we provide high-quality Prostate Cancer Samples for research along with other biospecimens to support biomarker discovery, diagnostics, and drug development.

Our comprehensive range of biospecimens includes:

If you have any questions, concerns, or special requests, please don’t hesitate to contact us.